ASSURE Wearable ECG vs TeraRecon Cardiovascular.Calcification.CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
ASSURE Wearable ECG
by Kestra Medical Technologies
VS
TeraRecon Cardiovascular.Calcification.CT
by Terarecon

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiac patient care. Tool A focuses on continuous, real-time heart rate monitoring and data collection via a wearable ECG, ideal for ongoing patient surveillance. In contrast, Tool B is an AI-powered software for analyzing CT images to detect and measure coronary artery calcifications and perform detailed vessel analysis, serving diagnostic imaging interpretation.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and real-time event detection for at-risk cardiac patients in an outpatient setting. This tool is ideal for remote patient management, providing clinicians with immediate alerts and physiologic trend data to intervene proactively.

View ASSURE Wearable ECG →

Choose TeraRecon Cardiovascular.Calcification.CT if…

Choose TeraRecon Cardiovascular.Calcification.CT if your primary need is automated, precise quantification of coronary artery calcification from CT images for diagnostic and risk stratification purposes. This software excels in providing detailed anatomical insights, including Agatston scores and vessel analysis, crucial for pre-operative planning and comprehensive cardiac assessment.

View TeraRecon Cardiovascular.Calcification.CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ASSURE Wearable ECG TeraRecon Cardiovascular.Calcification.CT
Pricing Contact for pricing. Subscription-based
Deployment Wearable device, mobile application, and cloud-based remote patient data platform. Containerized application (SaMD), also available as SaaS within Eureka Clinical AI platform.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool A, the ASSURE Wearable ECG, emphasizes patient-centric usability with its 'intuitive, mobile' design and 'SensorFit Garment' for comfortable, non-adhesive wear, crucial for continuous monitoring adherence. While Tool B offers high clinical usability through 'zero-click' automation for clinicians, Tool A's focus on making the patient's interaction with the device seamless for long-term use gives it an edge in overall usability.

Clinical Value

TeraRecon Cardiovascular.Calcification.CT

Tool B, TeraRecon Cardiovascular.Calcification.CT, provides highly precise and automated diagnostic insights from CT imaging, including 3D segmentation and quantitative calcium scoring (Agatston, volume, mean mass). This directly supports critical clinical decisions in risk stratification and pre-operative planning. While Tool A offers valuable continuous monitoring, Tool B's ability to automate complex, quantitative measurements for established diagnostic pathways provides a more concrete and high-impact clinical value in the diagnostic and interventional phases of care.

Pricing & Value

TeraRecon Cardiovascular.Calcification.CT

Tool B offers greater pricing transparency with a 'subscription-based' model and a 'single annual fee' that 'eliminates annual service renewals' and provides 'operational budget flexibility.' This predictable cost structure is highly valued by healthcare organizations for financial planning. Tool A's 'contact for pricing' approach offers no upfront information, making it less transparent for potential customers.

Enterprise Readiness

TeraRecon Cardiovascular.Calcification.CT

Both tools demonstrate foundational enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, Tool B's flexible deployment as a 'containerized application (SaMD)' and its availability as 'SaaS within Eureka Clinical AI platform' indicates a more robust and scalable integration strategy within diverse enterprise IT infrastructures. This platform-centric approach often implies greater ease of management and broader compatibility for large-scale deployments.

Innovation

TeraRecon Cardiovascular.Calcification.CT

Tool B's innovation in 'AI-powered software as a medical device' for 'Automatic 3D segmentation of calcified plaques' and 'zero-click centerline creation' represents a significant advancement in automating complex, time-consuming image analysis. This fundamentally transforms diagnostic workflows by improving efficiency and accuracy. While Tool A offers innovative wearable design and signal processing, Tool B's 'zero-click' automation for precise quantitative measurements in diagnostic imaging is a more disruptive innovation in its field.

Support & Docs

TeraRecon Cardiovascular.Calcification.CT

Tool B, TeraRecon, demonstrates an established framework for support and documentation, with web searches revealing mentions of 'Customer Support,' 'Instructions for Use (IFU),' and specific user guides like 'Intuition Client User Guide' and contact information. In contrast, Tool A's provided information and web searches did not yield explicit details regarding its customer support or documentation, making it difficult to assess its readiness in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ASSURE Wearable ECG TeraRecon Cardiovascular.Calcification.CT
Primary Function Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. AI-powered software that analyzes CT images to automatically detect and measure calcifications in the coronary arteries.
Company Kestra Medical Technologies Terarecon
Target Specialties Cardiology Cardiology, Cardiothoracic Surgery, Radiology
Core Technology/Methodology Wearable ECG device with SensorFit Garment and ASSURE Detection Algorithm with Quad Channel Processingu2122. AI-powered software for automatic 3D segmentation of calcified plaques in coronary arteries from CT images.
Key Output/Measurement Continuous heart rate monitoring, automatic episode storage, alert-based notifications, physiologic trend data. Outputs mask for calcium scoring systems, supports Agatston score, volume, mean mass (mg) measurements.
Motion Artifact Handling Adaptive Patient Intelligenceu2122 for filtering motion artifacts. Not specified

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and TeraRecon Cardiovascular.Calcification.CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ASSURE Wearable ECG supports continuous, remote heart rate monitoring for at-risk cardiac patients, providing data and alerts for ongoing management. TeraRecon Cardiovascular.Calcification.CT, an AI-powered SaMD, integrates into diagnostic imaging workflows to automatically detect and measure coronary artery calcifications from CT images, aiding in risk stratification and treatment planning.
The ASSURE Wearable ECG utilizes an ASSURE Detection Algorithm with Quad Channel Processingu2122 and Adaptive Patient Intelligenceu2122 to filter motion artifacts, enhancing the accuracy of continuous heart rate monitoring. TeraRecon Cardiovascular.Calcification.CT employs automatic 3D segmentation of calcified plaques for precise identification and measurement, supporting standardized calcium scoring systems like Agatston score, volume, and mean mass measurements.
The ASSURE Wearable ECG is particularly suited for cardiologists managing patients requiring continuous, long-term heart rate monitoring for rhythm disturbances or post-event surveillance. TeraRecon Cardiovascular.Calcification.CT is highly beneficial for radiologists and cardiothoracic surgeons needing precise calcium scoring and detailed coronary artery analysis for diagnostic and pre-operative planning, including vessel segmentation and functional analysis.
The ASSURE Wearable ECG, with its intuitive wearable device and mobile application, likely offers a rapid learning curve for patients and clinicians, providing immediate value through continuous data and alert-based notifications. TeraRecon Cardiovascular.Calcification.CT's automated AI features, such as zero-click centerline creation, aim to quickly integrate into existing CT reading workflows, accelerating diagnostic insights and potentially reducing analysis time.
The ASSURE Wearable ECG's Kestra CareStation remote patient data platform stores automatic episodes and physiologic trend data, which would typically include audit trails for clinician review of monitoring activities. TeraRecon Cardiovascular.Calcification.CT, as a software as a medical device (SaMD), outputs DICOM result files and is intended to be used by trained professionals, implying robust logging and audit features to track image analysis and scoring for clinical oversight.
For the ASSURE Wearable ECG, multi-site rollout involves distributing wearable devices, onboarding patients to the mobile application, and centralizing data review via the cloud-based Kestra CareStation platform. TeraRecon Cardiovascular.Calcification.CT, available as a containerized application or SaaS within the Eureka Clinical AI platform, offers flexibility for deployment across various sites, potentially leveraging existing infrastructure for standardized access and management.
The ASSURE Wearable ECG is integrated into Kestra's digital healthcare platform, suggesting capabilities for data export or API-based integration with EHRs for patient records and trend data. TeraRecon Cardiovascular.Calcification.CT, as part of the Eureka Clinical AI platform, is designed to integrate with existing Radiology or Cardiology Picture Archiving and Communication Systems (PACS) and can output DICOM result files, which can then be utilized by other DICOM-compliant systems, including EHRs, for automated reporting of cardiac analysis results.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring ASSURE Wearable ECG or TeraRecon Cardiovascular.Calcification.CT

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.